15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering NovaBridge Biosciences, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $9.00 to $9.00, so the covering firms are broadly aligned. The average target of $9.00 sits 406% above the current $1.78. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to NovaBridge Biosciences.
As of Jul, 4 of 4 firms rate NBP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering NovaBridge Biosciences
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NBP.
#1
Andres Y. Maldonado
HC Wainwright & Co. · Rank #211
Buy
$9.00+405.6% to target
Overall win rate
38%
+ Follow
#2
Justin Zelin
BTIG
Buy
$9.00+405.6% to target
Coverage
—
+ Follow
#3
Daina Graybosch
Leerink Partners
Buy
$9.00+405.6% to target
Coverage
—
+ Follow
#4
KR
Kumaraguru Raja
Brookline Capital Markets
Buy
$8.00+349.4% to target
Coverage
—
+ Follow
#5
CL
Christopher Liu
Lucid Capital
Buy
$5.00+180.9% to target
Coverage
—
+ Follow
NBP stock forecast FAQ
What is NBP's average 12-month price target?+
The 1 analysts with a live target average $9.00 for NovaBridge Biosciences over the next 12 months, ranging from a $9.00 high to a $9.00 low.
Is NBP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover NBP?+
4 analysts have an active rating on NovaBridge Biosciences, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering NBP?+
Among analysts who currently cover NBP, Andres Y. Maldonado of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #211). Their current call is Buy with a $9.00 target.
Have analysts been upgrading or downgrading NBP lately?+
As of Jul, 4 of 4 firms rate NBP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NBP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
